Fatal inhalational anthrax in a 94-year-old Connecticut woman
- PMID: 11851578
- DOI: 10.1001/jama.287.7.863
Fatal inhalational anthrax in a 94-year-old Connecticut woman
Abstract
We describe the 11th case of bioterrorism-related inhalational anthrax reported in the United States. The presenting clinical features of this 94-year-old woman were subtle and nondistinctive. The diagnosis was recognized because blood cultures were obtained prior to administration of antibiotics, emphasizing the importance of this diagnostic test in evaluating ill patients who have been exposed to Bacillus anthracis. The patient's clinical course was characterized by progression of respiratory insufficiency, pleural effusions and pulmonary edema, and, ultimately, death. Although her B anthracis bacteremia was rapidly sterilized after initiation of antibiotic therapy, viable B anthracis was present in postmortem mediastinal lymph node specimens. The source of exposure to B anthracis in this patient is not known. Exposure to mail that was cross-contaminated as it passed through postal facilities contaminated with B anthracis spores is one hypothesis under investigation.
Comment in
-
Bioterrorism preparedness and response: clinicians and public health agencies as essential partners.JAMA. 2002 Feb 20;287(7):898-900. doi: 10.1001/jama.287.7.898. JAMA. 2002. PMID: 11851584 No abstract available.
Similar articles
-
Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City.JAMA. 2002 Feb 20;287(7):858-62. doi: 10.1001/jama.287.7.858. JAMA. 2002. PMID: 11851577
-
Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.MMWR Morb Mortal Wkly Rep. 2001 Nov 30;50(47):1049-51. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11808925
-
Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001.Emerg Infect Dis. 2003 Jun;9(6):681-8. doi: 10.3201/eid0906.020728. Emerg Infect Dis. 2003. PMID: 12781007 Free PMC article.
-
Inhalational anthrax and bioterrorism.Curr Opin Pulm Med. 2003 May;9(3):221-6. doi: 10.1097/00063198-200305000-00011. Curr Opin Pulm Med. 2003. PMID: 12682568 Review.
-
When bioterrorism strikes: diagnosis and management of inhalational anthrax.Semin Respir Infect. 2003 Sep;18(3):134-45. Semin Respir Infect. 2003. PMID: 14505276 Review.
Cited by
-
Genetic barcodes for improved environmental tracking of an anthrax simulant.Appl Environ Microbiol. 2012 Dec;78(23):8272-80. doi: 10.1128/AEM.01827-12. Epub 2012 Sep 21. Appl Environ Microbiol. 2012. PMID: 23001658 Free PMC article.
-
Comprehensive characterization of toxins during progression of inhalation anthrax in a non-human primate model.PLoS Pathog. 2022 Dec 19;18(12):e1010735. doi: 10.1371/journal.ppat.1010735. eCollection 2022 Dec. PLoS Pathog. 2022. PMID: 36534695 Free PMC article.
-
Toll-like receptor 4 knockout protects against anthrax lethal toxin-induced cardiac contractile dysfunction: role of autophagy.Br J Pharmacol. 2012 Oct;167(3):612-26. doi: 10.1111/j.1476-5381.2012.02040.x. Br J Pharmacol. 2012. PMID: 22612289 Free PMC article.
-
Alternative pre-approved and novel therapies for the treatment of anthrax.BMC Infect Dis. 2016 Nov 3;16(1):621. doi: 10.1186/s12879-016-1951-y. BMC Infect Dis. 2016. PMID: 27809794 Free PMC article. Review.
-
Pathophysiological manifestations in mice exposed to anthrax lethal toxin.Infect Immun. 2005 Oct;73(10):7006-10. doi: 10.1128/IAI.73.10.7006-7010.2005. Infect Immun. 2005. PMID: 16177381 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical